SWK Holdings Corp
NASDAQ:SWKH
Intrinsic Value
SWK Holdings Corp. is engaged in the business of financial and asset management in the field of pharmaceutical. [ Read More ]
The intrinsic value of one SWKH stock under the Base Case scenario is 13.19 USD. Compared to the current market price of 17.01 USD, SWK Holdings Corp is Overvalued by 22%.
Valuation Backtest
SWK Holdings Corp
Run backtest to discover the historical profit from buying and selling SWKH stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
SWK Holdings Corp
Current Assets | 11.9m |
Cash & Short-Term Investments | 4.5m |
Receivables | 4.7m |
Other Current Assets | 2.6m |
Non-Current Assets | 322.4m |
Long-Term Investments | 48k |
PP&E | 5.4m |
Intangibles | 6.5m |
Other Non-Current Assets | 310.4m |
Current Liabilities | 3.9m |
Accounts Payable | 3.9m |
Other Current Liabilities | 9k |
Non-Current Liabilities | 50m |
Long-Term Debt | 43.1m |
Other Non-Current Liabilities | 6.9m |
Earnings Waterfall
SWK Holdings Corp
Revenue
|
37.8m
USD
|
Operating Expenses
|
-19.2m
USD
|
Operating Income
|
18.6m
USD
|
Other Expenses
|
-2.7m
USD
|
Net Income
|
15.9m
USD
|
Free Cash Flow Analysis
SWK Holdings Corp
SWKH Profitability Score
Profitability Due Diligence
SWK Holdings Corp's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
SWK Holdings Corp's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
SWKH Solvency Score
Solvency Due Diligence
SWK Holdings Corp's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Score
SWK Holdings Corp's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SWKH Price Targets Summary
SWK Holdings Corp
According to Wall Street analysts, the average 1-year price target for SWKH is 24.48 USD with a low forecast of 22.22 USD and a high forecast of 27.3 USD.
Ownership
SWKH Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
SWKH Price
SWK Holdings Corp
Average Annual Return | 17.3% |
Standard Deviation of Annual Returns | 20.71% |
Max Drawdown | -48% |
Market Capitalization | 212.6m USD |
Shares Outstanding | 12 497 100 |
Percentage of Shares Shorted | 2.05% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
SWK Holdings Corp. is engaged in the business of financial and asset management in the field of pharmaceutical. The company is headquartered in Dallas, Texas and currently employs 35 full-time employees. The firm is focused on providing various capital solutions to a range of life science companies, institutions and inventors. The firm operates through two segments: Finance Receivables and Pharmaceutical Development. Its Finance Receivables segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. In addition, through its wholly owned subsidiary, SWK Advisors LLC, it provides non-discretionary investment advisory services to institutional clients in separately managed accounts to similarly invest in life science finance. Through its subsidiary, Enteris BioPharma, Inc., its Pharmaceutical Development segment offers formulation solutions built around its oral drug delivery technology, the Peptelligence platform.
Contact
IPO
Employees
Officers
The intrinsic value of one SWKH stock under the Base Case scenario is 13.19 USD.
Compared to the current market price of 17.01 USD, SWK Holdings Corp is Overvalued by 22%.